Unknown

Dataset Information

0

Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.


ABSTRACT: Over the past 20 years, there has been tremendous progress in retinal gene therapy. The safety and efficacy results in one early-onset severe blinding disease may lead to the first gene therapy drug approval in the United States. Here, we review how far the field has come over the past two decades and speculate on the directions that the field will take in the future.

SUBMITTER: Bennett J 

PROVIDER: S-EPMC5417792 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.

Bennett Jean J  

Molecular therapy : the journal of the American Society of Gene Therapy 20170405 5


Over the past 20 years, there has been tremendous progress in retinal gene therapy. The safety and efficacy results in one early-onset severe blinding disease may lead to the first gene therapy drug approval in the United States. Here, we review how far the field has come over the past two decades and speculate on the directions that the field will take in the future. ...[more]

Similar Datasets

| S-EPMC7035148 | biostudies-literature
| S-EPMC5603759 | biostudies-literature
| S-EPMC5329133 | biostudies-other
| S-EPMC7792918 | biostudies-literature
| S-EPMC7245803 | biostudies-literature
| S-EPMC9278499 | biostudies-literature
| S-EPMC6454441 | biostudies-literature
| S-EPMC8581403 | biostudies-literature
| S-EPMC5055059 | biostudies-literature
| S-EPMC6151711 | biostudies-literature